A detailed history of Mather Group, Llc. transactions in Insulet Corp stock. As of the latest transaction made, Mather Group, Llc. holds 870 shares of PODD stock, worth $242,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
870
Previous 816 6.62%
Holding current value
$242,642
Previous $189,000 20.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$227.79 - $275.7 $12,300 - $14,887
54 Added 6.62%
870 $227,000
Q3 2024

Oct 07, 2024

BUY
$180.69 - $239.01 $62,699 - $82,936
347 Added 73.99%
816 $189,000
Q2 2024

Jul 08, 2024

BUY
$161.02 - $206.98 $25,280 - $32,495
157 Added 50.32%
469 $94,000
Q1 2024

Apr 08, 2024

BUY
$163.6 - $209.11 $51,043 - $65,242
312 New
312 $53,000
Q2 2023

Aug 08, 2023

BUY
$272.48 - $330.23 $13,624 - $16,511
50 New
50 $14,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.